DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 107 filers reported holding DEPOMED INC in Q4 2013. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,280,000 | -28.8% | 348,480 | -1.3% | 0.10% | -34.9% |
| Q3 2016 | $8,815,000 | +26.3% | 353,030 | -0.7% | 0.15% | +22.7% |
| Q2 2016 | $6,977,000 | +39.7% | 355,630 | -0.8% | 0.12% | +22.7% |
| Q1 2016 | $4,993,000 | -23.3% | 358,430 | -0.2% | 0.10% | -30.2% |
| Q4 2015 | $6,513,000 | +5.9% | 359,230 | +30.9% | 0.14% | -29.1% |
| Q1 2015 | $6,152,000 | +38.7% | 274,500 | -0.3% | 0.20% | +22.5% |
| Q4 2014 | $4,437,000 | +7.7% | 275,400 | +1.5% | 0.16% | -9.6% |
| Q3 2014 | $4,121,000 | +9.3% | 271,300 | 0.0% | 0.18% | +10.6% |
| Q2 2014 | $3,771,000 | -15.7% | 271,300 | -12.1% | 0.16% | -25.9% |
| Q1 2014 | $4,475,000 | +22.6% | 308,600 | -10.5% | 0.22% | +7.5% |
| Q4 2013 | $3,649,000 | +38.1% | 344,900 | -2.5% | 0.20% | +27.2% |
| Q3 2013 | $2,642,000 | +30.9% | 353,700 | -1.5% | 0.16% | +11.3% |
| Q2 2013 | $2,018,000 | – | 359,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 1,876,195 | $42,045,000 | 9.16% |
| Senvest Management, LLC | 3,331,531 | $74,660,000 | 4.62% |
| Krensavage Asset Management, LLC | 343,546 | $7,699,000 | 3.51% |
| PERKINS CAPITAL MANAGEMENT INC | 97,950 | $2,195,000 | 1.84% |
| HAYS ADVISORY LLC | 580,069 | $12,999,000 | 1.68% |
| ARBOR CAPITAL MANAGEMENT LLC | 572,200 | $12,823,000 | 1.54% |
| Broadfin Capital, LLC | 705,204 | $15,804,000 | 1.23% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 556,311 | $13,969,000 | 1.14% |
| Pier Capital, LLC | 330,682 | $7,411,000 | 1.12% |
| TURNER INVESTMENTS LLC | 259,357 | $5,812,000 | 1.04% |